Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.


Make a donation

About Clinical Trials

Clinical trials allow researchers to gather information on a drug's dose, effectiveness and safety in humans. Their study protocol (written plan) is designed to answer key research questions by comparing results from the different treatment arms (groups) that include either the experimental drug, standard of care, standard of care plus placebo or their various combinations. These studies can be conducted by a single researcher in one hospital or clinic, or by many researchers at the national or international (global) level. Because clinical trial research involves both drugs and people, there are strict regulations in place to ensure the safety of participants.

Based on the specifics of your myeloma diagnosis, a clinical trial may be an option to consider. There are clinical trials that are designed for each phase of the disease. The medical team may recommend turning to new drugs or combinations of treatments that are only available through participation in clinical trials. Clinical trials may provide access to drugs or combinations of treatments that are not yet approved by Health Canada and are unavailable to patients, or that are approved by Health Canada but not covered by provincial governments.